open access

Vol 4, No 3 (2019)
ORIGINAL ARTICLES
Published online: 2019-10-08
Get Citation

Risk factors for adverse events in patients administered intravenous tramadol hydrochloride in Emergency Department

Eylem Kuday Kaykısız, Hatice Onturk, Lukasz Szarpak, Burak Katipoğlu, Semih Korkut
DOI: 10.5603/DEMJ.2019.0019
·
Disaster Emerg Med J 2019;4(3):92-97.

open access

Vol 4, No 3 (2019)
ORIGINAL ARTICLES
Published online: 2019-10-08

Abstract

INTRODUCTION: The aim of the present study was to assess the adverse events developing in patients treating with intravenous(iv) tramadol to provide moderate to severe pain control in emergency department (ED) and to investigate the association of these adverse events with age, sex and vital signs and to compose a set of rules for the identification of patients in the risk group. 

MATERIAL AND METHODS: In this prospective cohort study, patients older than 18 years, admitted to ED during a 1-year period and administered iv tramadol were included in a secondary care public hospital. Information about age, sex, vital signs and adverse events were recorded. Patients defined as group 1 or group 2 with respect to adverse event development status and the groups were compared in terms of age, sex and vital signs. 

RESULTS: A total of 408 patients were included in the study. Adverse events ratio after treatment was 21.1%. Adverse events were nausea, dizziness and vomiting. The age and the pulse rate per minute of the patients in group 1 were found to be higher and systolic blood pressure (SBP) was found to be lower than the patients in group 2. 

CONCLUSİONS: The risk of adverse events development is higher in patients who are hypotensive, tachycardic and older than 56 years. Multicenter, prospective studies with larger patient groups are needed to support our results.

Abstract

INTRODUCTION: The aim of the present study was to assess the adverse events developing in patients treating with intravenous(iv) tramadol to provide moderate to severe pain control in emergency department (ED) and to investigate the association of these adverse events with age, sex and vital signs and to compose a set of rules for the identification of patients in the risk group. 

MATERIAL AND METHODS: In this prospective cohort study, patients older than 18 years, admitted to ED during a 1-year period and administered iv tramadol were included in a secondary care public hospital. Information about age, sex, vital signs and adverse events were recorded. Patients defined as group 1 or group 2 with respect to adverse event development status and the groups were compared in terms of age, sex and vital signs. 

RESULTS: A total of 408 patients were included in the study. Adverse events ratio after treatment was 21.1%. Adverse events were nausea, dizziness and vomiting. The age and the pulse rate per minute of the patients in group 1 were found to be higher and systolic blood pressure (SBP) was found to be lower than the patients in group 2. 

CONCLUSİONS: The risk of adverse events development is higher in patients who are hypotensive, tachycardic and older than 56 years. Multicenter, prospective studies with larger patient groups are needed to support our results.

Get Citation

Keywords

tramadol hydrochloride; opioids analgesics; emergency department; adverse event; side effect

About this article
Title

Risk factors for adverse events in patients administered intravenous tramadol hydrochloride in Emergency Department

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 4, No 3 (2019)

Pages

92-97

Published online

2019-10-08

DOI

10.5603/DEMJ.2019.0019

Bibliographic record

Disaster Emerg Med J 2019;4(3):92-97.

Keywords

tramadol hydrochloride
opioids analgesics
emergency department
adverse event
side effect

Authors

Eylem Kuday Kaykısız
Hatice Onturk
Lukasz Szarpak
Burak Katipoğlu
Semih Korkut

References (17)
  1. Cordell WH, Keene KK, Giles BK, et al. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002; 20(3): 165–169.
  2. Grenman D, Niemi-Murola L, Kalso E. Management of pain in a surgical emergency unit—Underlying factors affecting its delivery. Acute Pain. 2008; 10(3-4): 137–144.
  3. Pain management in the emergency department. Annals of Emergency Medicine. 2004; 44(2): 198.
  4. Smith MD, Wang Y, Cudnik M, et al. The effectiveness and adverse events of morphine versus fentanyl on a physician-staffed helicopter. J Emerg Med. 2012; 43(1): 69–75.
  5. Institute for Safe Medication Practices. ISMP’s list of high alert medications. https://ismp.org/Tools/highalertmedications.pdf (29.06.2010).
  6. Barkin RL. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008; 15(2): 157–166.
  7. Wu CL, Naqibuddin M, Fleisher LA. Measurement of patient satisfaction as an outcome of regional anesthesia and analgesia: a systematic review. Reg Anesth Pain Med. 2001; 26(3): 196–208.
  8. Schug SA. Patient satisfaction--politically correct fashion of the nineties or a valuable measure of outcome? Reg Anesth Pain Med. 2001; 26(3): 193–195.
  9. Wu CL, Hurley RW, Anderson GF, et al. Effect of postoperative epidural analgesia on morbidity and mortality following surgery in medicare patients. Reg Anesth Pain Med. 2004; 29(6): 525–33; discussion 515.
  10. Niemi-Murola L, Unkuri J, Hamunen K. Parenteral opioids in emergency medicine — A systematic review of efficacy and safety. Scand J Pain. 2011; 2(4): 187–194.
  11. Daoust R, Paquet J, Lavigne G, et al. Impact of age, sex and route of administration on adverse events after opioid treatment in the emergency department: a retrospective study. Pain Res Manag. 2015; 20(1): 23–28.
  12. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003; 74(2): 102–112.
  13. Bijur PE, Esses D, Birnbaum A, et al. Response to morphine in male and female patients: analgesia and adverse events. Clin J Pain. 2008; 24(3): 192–198.
  14. Zun LS, Downey LaV, Gossman W, et al. Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med. 2002; 20(3): 151–154.
  15. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003; 74(2): 102–112.
  16. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001; 16(4): 266–275.
  17. Chang AK, Bijur PE, Gallagher EJ. Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain. Ann Emerg Med. 2011; 58(4): 352–359.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl